Diseases, Conditions, Syndromes

Coronavirus: Study finds further door opener into the cell

The coronavirus SARS-CoV-2 is known to infect cells via the receptor ACE2. An international research team under German-Finnish coordination has now identified neuropilin-1 as a factor that can facilitate SARS-CoV-2 entry ...

Medications

Stomach-protecting medicines can trigger allergies

Stomach-protecting drugs are widely used. Now, using quantitative prescribing data from Austria, a study conducted by MedUni Vienna in collaboration with the Austrian Social Insurance Institutions, has shown that stomach-protecting ...

Immunology

Bacteria therapy for eczema shows promise in new study

Topical treatment with live Roseomonas mucosa—a bacterium naturally present on the skin—was safe for adults and children with atopic dermatitis (eczema) and was associated with reduced disease severity, according to initial ...

Diseases, Conditions, Syndromes

Helicobacter creates immune system blind spot

The gastric bacterium H. pylori colonizes the stomachs of around half the human population and can lead to the development of gastric cancer. It is usually acquired in childhood and persists life-long, despite a strong inflammatory ...

Medical research

Mitochondria control stem cell fate

What happens in intestinal epithelial cells during a chronic illness? Basic research conducted at the Chair of Nutrition and Immunology at the Technical University of Munich (TUM) addressed this question by generating a new ...

Medications

New discovery leads to novel probiotic for eczema

NIAID research has led to the availability of a new over-the-counter topical eczema probiotic. The probiotic is based on the discovery by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part ...

page 3 from 13